Orthopedics This Week has recently named the ClearEdge Brain Health Toolkit, from Syracuse, NY-based Quadrant Biosciences Inc, the Best Sports Medical Technology of 2018.
The award was presented to the company at the recent American Orthopaedic Society for Sports Medicine meeting in San Diego.
“I am very honored to accept the Sports Technology Award from Orthopedics This Week on behalf of all of my colleagues at Quadrant who have worked tirelessly for several years to bring this vitally important product to market,” says Richard Uhlig, founder and CEO of Quadrant Biosciences, in a media release.
The ClearEdge toolkit is a suite of tests that includes cognitive assessment, balance and symptoms tracking.
It was designed in conjunction with SUNY Upstate Medical University as a way to objectively and quantitatively assess and monitor indicators of brain health such as concussion, in response to the growing concern over brain health and injury and the need for more objective assessment tools. It was commercially released in the Fall of 2017.
Objectively measuring and tracking subtle changes in balance and cognitive function has utility for a number of neurological and other applications. As a result, ClearEdge has partnered with national organizations interested in regular brain health monitoring such as the U.S. Allstar Federation (USASF) for cheerleading and dance, Team Tokey Hill Karate, and the Hall of Fame Player’s Foundation.
According to Uhlig, “several more partnerships” are in the works as ClearEdge continues to gain clinical adoption across the country, the release continues.
[Source(s): Quadrant Biosciences Inc, PR Newswire]